pinaverium has been researched along with Diarrhea in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Lv, X; Qin, J; Qin, L; Yang, Q | 1 |
Ai, YW; Chen, SN; Feng, PM; Hou, XH; Li, HZ; Li, K; Li, ZH; Tang, XD; Wang, HY; Wu, JQ; Xia, PJ; Yang, XJ; Yang, XN; Zhang, SS; Zhou, HJ | 1 |
Chen, JX; Chen, MX; Fu, R; Lu, Z; Xia, L | 1 |
Chen, YL; Chu, YJ; Jia, BL; Lan, L; Tang, SX; Wang, J; Xia, GD; Zhang, H | 1 |
Gao, WY; Lin, YF; Wang, CH | 1 |
Li, H; Pei, LX; Zhou, JL | 1 |
Cai, G; Shen, Y; Sun, X | 1 |
Mearin, F | 1 |
Chang, FY; Chang, SS; Chen, CY; Kang, LJ; Lee, SD; Lu, CL; Lu, RH | 1 |
2 review(s) available for pinaverium and Diarrhea
Article | Year |
---|---|
Efficacy and safety of pinaverium bromide combined with flupentixol-melitracen for diarrhea-type irritable bowel syndrome: A systematic review and meta-analysis.
Topics: Anthracenes; Diarrhea; Drug Combinations; Drug Therapy, Combination; Flupenthixol; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Morpholines; Randomized Controlled Trials as Topic | 2019 |
[Drug treatment of irritable bowel syndrome: an unmet need].
Topics: Abdominal Pain; Analgesics; Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Controlled Clinical Trials as Topic; Diarrhea; Dicyclomine; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Life Style; Loperamide; Meta-Analysis as Topic; Morpholines; Muscarinic Antagonists; Odds Ratio; Parasympatholytics; Phenethylamines; Quality of Life; Risk; Scopolamine; Scopolamine Derivatives; Serotonin Antagonists; Serotonin Receptor Agonists; Surveys and Questionnaires; Time Factors; Treatment Outcome; Trimebutine | 2007 |
7 trial(s) available for pinaverium and Diarrhea
Article | Year |
---|---|
Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
Topics: Adult; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Morpholines; Product Surveillance, Postmarketing; Quality of Life; Surveys and Questionnaires | 2019 |
[Treating irritable bowel syndrome with diarrhea patients by yigan fupi decoction: a randomized controlled trial].
Topics: Adult; Diarrhea; Drugs, Chinese Herbal; Female; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Morpholines; Quality of Life; Treatment Outcome | 2014 |
Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.
Topics: Abdominal Pain; Adult; Aged; Anti-Anxiety Agents; Anxiety; Calcium Channel Blockers; China; Diarrhea; Drug Administration Schedule; Female; Humans; Irritable Bowel Syndrome; Isoindoles; Male; Middle Aged; Morpholines; Pain Measurement; Piperazines; Prospective Studies; Pyrimidines; Single-Blind Method; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2014 |
[Effect of jianpi tiaogan wenshen recipe in treating diarrhea-predominant irritable bowel syndrome].
Topics: Adolescent; Adult; Diarrhea; Drugs, Chinese Herbal; Female; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Morpholines; Phytotherapy; Prospective Studies; Young Adult | 2010 |
[Comparative observation on therapeutic effects between acupuncture and western medication for diarrhea-predominant irritable bowel syndrome].
Topics: Acupuncture Points; Adult; Diarrhea; Electroacupuncture; Female; Humans; Irritable Bowel Syndrome; Liver; Male; Middle Aged; Morpholines; Quality of Life; Spleen; Treatment Outcome | 2012 |
[Randomized controlled clinical study on effect of Chinese compound changjitai in treating diarrheic irritable bowel syndrome].
Topics: Adult; Diarrhea; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Morpholines; Phytotherapy | 2003 |
Effect of a calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome.
Topics: Calcium Channel Blockers; Colonic Diseases, Functional; Diarrhea; Female; Gastrointestinal Motility; Humans; Immunoenzyme Techniques; Male; Middle Aged; Morpholines; Neuropeptide Y; Parasympatholytics; Phenethylamines; Statistics, Nonparametric; Substance P; Surveys and Questionnaires; Treatment Outcome | 2000 |